In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria (Q39895467)

15 September 2017

In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria (English)

1 reference

15 September 2017

Ellie J. C. Goldstein

series ordinal

4

object named as

E J C Goldstein

1 reference

15 September 2017

2

K L Tyrrell

1 reference

15 September 2017

1

D M Citron

1 reference

15 September 2017

3

C V Merriam

1 reference

PMCID

2849373

15 September 2017

language of work or name

English

0 references

publication date

25 January 2010

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

54

1 reference

15 September 2017

4

1 reference

15 September 2017

1627-1632

1 reference

Ceftaroline: a cephalosporin with expanded Gram-positive activity

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

A retrospective review of cases of anaerobic empyema and update of bacteriology

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Anaerobic bacterial infections of the lung and pleural space

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

National hospital survey of anaerobic culture and susceptibility methods: III.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Microbiology of Severe Aspiration Pneumonia in Institutionalized Elderly

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

Bacteriology of anaerobic pleuropulmonary infections: preliminary report

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849373

20 August 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20100877

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.01788-09

1 reference

release_6eyotrvdmjew5fzhsbymxzajym

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6eyotrvdmjew5fzhsbymxzajym

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

2849373

1 reference

15 September 2017

1 reference

PMCID

2849373